(Q84755383)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19844224%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

title

When to conduct a renal impairment study during drug development: US Food and Drug Administration perspective (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19844224%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

S-M Huang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19844224%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

R Temple

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19844224%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

S Xiao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19844224%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

L Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19844224%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

L J Lesko

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19844224%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

publication date

1 November 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19844224%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

10 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19844224%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19844224%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

475-479

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19844224%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19844224%20AND%20SRC:MED&resulttype=core&format=json

Is this the drug or dose for you? Impact and consideration of ethnic factors in global drug development, regulatory review, and clinical practice

10 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.190

7 January 2021

Assessment of the impact of renal impairment on systemic exposure of new molecular entities: evaluation of recent new drug applications

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.190

7 January 2021

Clinical pharmacology studies in patients with renal impairment: past experience and regulatory perspectives

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.190

7 January 2021

Emerging evidence of the impact of kidney disease on drug metabolism and transport

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.190

7 January 2021

Assessing kidney function--measured and estimated glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.190

7 January 2021

A new equation to estimate glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.190

7 January 2021

Comparison of estimated glomerular filtration rate with estimated creatinine clearance in the dosing of drugs requiring adjustments in elderly patients with declining renal function

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.190

7 January 2021

Identifiers

DOI

10.1038/CLPT.2009.190

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19844224%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference